E-LIB Suche - Ergebnisse für: Gonczi, L

1

P661 Ustekinumab in Crohn's disease: A three-year multicent..:

Barkai, L J ; Gonczi, L ; Farkas, K...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1259-i1259 , 2024

Link: https://doi.org/10.1093/..

2

DOP56 Long-term disease progression and resective surgery r..:

Gonczi, L ; Lakatos, L ; Golovics, P A...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i127-i128 , 2023

Link: https://doi.org/10.1093/..

3

OP09 Long-term Colectomy rates of Ulcerative Colitis over 4..:

Lakatos PhD, P L ; Gonczi, L ; Lakatos, L...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i14-i16 , 2023

Link: https://doi.org/10.1093/..

4

DOP63 Time Trends of Environmental and Socio-economical Fac..:

Wetwittayakhlang, P ; Gonczi, L ; Lakatos, L...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i137-i137 , 2023

Link: https://doi.org/10.1093/..

5

P829 The Burden of Colorectal Cancer in Patients with Ulcer..:

Wetwittayakhlang, P ; Golovics, P ; Gonczi, L...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i961-i962 , 2023

Link: https://doi.org/10.1093/..

6

P837 Incidence, evolution of disease phenotype, time to bio..:

Gonczi, L ; Lakatos, L ; Golovics, P A...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i966-i967 , 2023

Link: https://doi.org/10.1093/..

7

DOP26 Burden of perianal disease and perianal surgery in Cr..:

Gonczi, L ; Lakatos, L ; Golovics, P A...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i90-i91 , 2023

Link: https://doi.org/10.1093/..

8

P635 Incidence, prevalence, disease phenotype and maximal t..:

Lakatos, L ; Gonczi, L ; Golovics, P...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i554-i555 , 2022

Link: https://doi.org/10.1093/..

9

P578 Non-medical switch between adalimumab biosimilars and ..:

Lontai, L ; Gonczi, L ; Balogh, F...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i518-i519 , 2022

Link: https://doi.org/10.1093/..

10

P629 Evolution of disease phenotype, time to biological the..:

Gonczi, L ; Lakatos, L ; Golovics, P...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i551-i552 , 2022

Link: https://doi.org/10.1093/..

11

P640 Incidence, prevalence, disease phenotype and maximal t..:

Lakatos, L ; Gonczi, L ; Golovics, P...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i557-i558 , 2022

Link: https://doi.org/10.1093/..

12

P445 Is objective disease monitoring strategy tailored to t..:

Lontai, L ; Gonczi, L ; Komlodi, N...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i425-i426 , 2022

Link: https://doi.org/10.1093/..

13

P658 Evolution of disease phenotype, time to biological the..:

Gonczi, L ; Lakatos, L ; Golovics, P...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i569-i570 , 2022

Link: https://doi.org/10.1093/..

14

A174 PATIENT PERSPECTIVES AND EXPECTATIONS IN INFLAMMATORY ..:

Balram, B ; Al Khoury, A ; Bessissow, T...
Journal of the Canadian Association of Gastroenterology. 4 (2021) Supplement_1 - p. 185-186 , 2021

Link: https://doi.org/10.1093/..

15

P441 Clinical efficacy, drug sustainability and results fro..:

Gonczi, L ; Szanto, K ; Farkas, K...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S441-S441 , 2021

Link: https://doi.org/10.1093/..